KEY POINTS
- AAPM Medical Physics Practice Guideline 18.a establishes comprehensive physics practice recommendations for superficial radiation therapy using low-energy kilovoltage x-rays, typically 50–100 kVp. The guidance applies to dermatology and radiation oncology clinics treating nonmelanoma skin cancer and selected benign dermatological conditions. It addresses commissioning, routine QA, treatment calculations, clinical workflow, staff responsibilities, and radiation safety, while excluding electron therapy, HDR brachytherapy, and higher-energy orthovoltage treatment from its primary scope.
- Commissioning must be performed by a qualified medical physicist and include independent characterization of all clinically used beam configurations. Required measurements include half-value layer (HVL), absolute output calibration, applicator factors, percent depth dose (PDD), beam profiles, field-to-applicator congruence, and focal spot size. HVL must be measured before absolute output calibration, with dosimetry performed according to AAPM TG-61 or an equivalent standard rather than relying solely on manufacturer-provided beam quality data. Treatment time or monitor-unit calculation tools must also undergo documented commissioning and validation before clinical use.
- Daily QA includes defined numerical action limits and mandatory safety checks. Output constancy must remain within ±3% of the commissioning baseline, measured for the energy and filter combinations scheduled for treatment. The backup timer or backup monitor-unit system must meet a ±2% tolerance. Daily checks also cover machine warm-up, audiovisual monitoring, door and filter interlocks, beam-on indicators, emergency interruption, and correct energy-filter selection. Integrated ultrasound functionality must be checked when ultrasound-guided treatment is scheduled.
- Monthly QA expands verification to all clinically used energy and filter combinations. Output constancy remains subject to the ±3% baseline tolerance, while timer accuracy for time-based systems must be within ±2% or ±0.02 minutes. Additional checks include applicator integrity, mechanical stability, safety indicators, and filter interlock operation. The guideline allows appropriately trained personnel to conduct routine daily and monthly checks under the established medical physics QA framework, with documented results and independent review.
- Annual QA includes detailed dosimetric and geometric tolerances. HVL must remain within ±10% of baseline, absolute output calibration has a stated action limit of ±3.5% relative to the current clinical output, applicator factors must remain within ±2%, and applicable PDD measurements within ±3% of baseline. Beam profile verification requires ±5% agreement, while radiation field-to-applicator congruence must remain within ±2 mm. Output reproducibility is limited to 2%, and head tilt or rotation should not change output by more than ±2%. The document additionally requires output adjustment when deviations exceed ±5% of the clinical output.
- Treatment workflow requires independent verification before irradiation. The prescription must specify anatomical site and laterality, beam energy, filter, applicator size, fractionation, treatment depth, and applicable shielding or imaging instructions. Treatment time or monitor-unit calculations must be independently checked, and the approved plan must be reconciled with the treatment unit's clinical interface and electronic record. Unplanned applicator-to-skin air gaps should be minimized because of their dosimetric consequences, with patient-specific verification recommended for complex shielding or irregular treatment geometries. The guideline also recommends weekly chart review and requires an end-of-treatment review within five business days.
- Radiation protection, staff competency, and local regulatory compliance are integral components of the guideline. Facilities should complete structural shielding assessment, post-installation radiation surveys, personnel monitoring where applicable, documentation of machine maintenance, and initial and periodic staff training. Shielding must account for the highest clinically used energy and potential beam directions, particularly for mobile superficial x-ray systems. The recommendations were developed within the United States regulatory environment, so departments in other jurisdictions must reconcile them with their own national requirements. As a practice guideline, the report provides expert-consensus minimum standards rather than new comparative clinical outcome data.
CLINICAL TAKEAWAY
AAPM MPPG 18.a provides a comprehensive framework for commissioning, quality assurance, treatment verification, and radiation safety in low-energy superficial x-ray therapy. Its explicit numerical tolerances and workflow recommendations offer practical benchmarks for departmental QA programs, although implementation must remain consistent with local regulatory requirements and device-specific characteristics.